These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 16144019

  • 1. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J, Choi S, Hwang KS, Cho WK, Jung CR, Kwon ST, Im DS.
    J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
    Shi J, Zheng D, Liu Y, Sham MH, Tam P, Farzaneh F, Xu R.
    Cancer Res; 2005 Mar 01; 65(5):1687-92. PubMed ID: 15753363
    [Abstract] [Full Text] [Related]

  • 3. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H, Liu Y, Liu S, Xu R, Zheng D.
    Hepatology; 2005 Dec 01; 42(6):1355-63. PubMed ID: 16317690
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.
    Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289
    [Abstract] [Full Text] [Related]

  • 5. AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.
    Mohr A, Henderson G, Dudus L, Herr I, Kuerschner T, Debatin KM, Weiher H, Fisher KJ, Zwacka RM.
    Gene Ther; 2004 Mar 15; 11(6):534-43. PubMed ID: 14999225
    [Abstract] [Full Text] [Related]

  • 6. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
    Xia JT, Xu B, Wang SC, Lai YY, Wu ZF, Li SH, Li W.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 08; 88(26):1846-50. PubMed ID: 19040022
    [Abstract] [Full Text] [Related]

  • 7. [Expression of TRAIL(114-281) mediated by adeno-associated virus and its tumoricidal activity].
    Ma H, Liu YX, Liu SL, Xu RA, Zheng DX.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 02; 84(19):1635-41. PubMed ID: 15569460
    [Abstract] [Full Text] [Related]

  • 8. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 02; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 9. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.
    Neurosurgery; 2009 Sep 02; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [Abstract] [Full Text] [Related]

  • 10. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
    Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B.
    Gene Ther; 2002 Oct 02; 9(20):1379-86. PubMed ID: 12365003
    [Abstract] [Full Text] [Related]

  • 11. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

  • 12. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W, Jiang Z, Xiang TX, Tao XH, Huang AL, Wang PL.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):841-5. PubMed ID: 19595126
    [Abstract] [Full Text] [Related]

  • 13. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B.
    Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263
    [Abstract] [Full Text] [Related]

  • 14. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.
    J Gene Med; 2008 May 01; 10(5):518-26. PubMed ID: 18338833
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 01; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 16. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 17. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
    Wu X, He Y, Falo LD, Hui KM, Huang L.
    Mol Ther; 2001 Mar 15; 3(3):368-74. PubMed ID: 11273779
    [Abstract] [Full Text] [Related]

  • 18. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Hum Pathol; 2005 Oct 15; 36(10):1066-73. PubMed ID: 16226105
    [Abstract] [Full Text] [Related]

  • 19. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C, Liu X.
    Hepatology; 2004 May 15; 39(5):1371-81. PubMed ID: 15122766
    [Abstract] [Full Text] [Related]

  • 20. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T, Ren C, Ponnazhagan S.
    Clin Cancer Res; 2005 Feb 01; 11(3):1342-7. PubMed ID: 15709207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.